SCHEMBL17102205

SCHEMBL17102205

NC(=O)CCCc1nc2ccc(-c3cn(S(=O)(=O)c4ccccc4)c4cc(F)ccc34)cc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 9/20 0.42
HTR2A P28223 3/20 0.42
HTR7 P34969 3/20 0.42
TRPV1 Q8NER1 2/20 0.41
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
IDO1 P14902 1/20 0.37
POLB P06746 1/20 0.37
DRD2 P14416 2/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36
TNKS O95271 1/20 0.36
PARP1 P09874 1/20 0.36
PARP2 Q9UGN5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17102224 0.96 HTR6 (0.42) HTR6HTR2AHTR7TRPV1ALDH1A1
SCHEMBL17097217 0.89 HTR6 (0.42) HTR6HTR2AHTR7TRPV1ALDH1A1
SCHEMBL17097134 0.89 IDO1 (0.50) HTR6HTR2AHTR7TRPV1CA12
SCHEMBL17102242 0.87 HTR6 (0.45) HTR6HTR2AHTR7TRPV1POLB
SCHEMBL17096764 0.86 HTR6 (0.47) HTR6HTR2AHTR7TRPV1
SCHEMBL17096726 0.86 HTR6 (0.42) HTR6HTR2AHTR7TRPV1ALDH1A1
SCHEMBL17097082 0.85 HTR6 (0.46) HTR6HTR2AHTR7TRPV1ALDH1A1
SCHEMBL17097305 0.84 KDM4E (0.45) HTR6HTR2AHTR7ALDH1A1CA12
SCHEMBL17097323 0.84 HTR6 (0.49) HTR6HTR2AHTR7DRD2MMP2
SCHEMBL17097214 0.84 HTR6 (0.43) HTR6HTR2AHTR7TRPV1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3119763-A1 NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE Iteos Therapeutics (BE) 2017-01-25 EP disclosed
WO-2015140717-A1 NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE ITEOS THERAPEUTICS (BE) 2015-09-24 WO disclosed